- Mechanism
- Stimulates GnRH release via GPR54 receptor activation
- Typical research dose
- 1-3 mcg/kg subcutaneous (research only)
- Route
- subcutaneous
- Half-life
- ~20-30 minutes
- Legal status
- Research Only
Overview
Kisspeptin-10 is a synthetic, truncated version of the naturally occurring kisspeptin protein, functioning as a critical regulator of the hypothalamic-pituitary-gonadal (HPG) axis. This potent neuropeptide stimulates the release of gonadotropin-releasing hormone (GnRH), making it essential for reproductive health and pubertal development. Beyond its primary role in fertility, emerging research highlights the Kisspeptin-10 peptide for its diverse physiological impacts, including neuroprotection, bone density maintenance, and cardiovascular regulation. Its broad therapeutic potential makes it a significant focus in both endocrinology and regenerative medicine.
Potential Benefits
- Reproductive Health & Fertility: The Kisspeptin-10 peptide stimulates the HPG axis, promoting progesterone synthesis and improving sperm quality in animal models (Guo L et al., 2022; Fayyaz MH et al., 2022).
- Neuroprotection: Research indicates it rescues neuronal cells from α-synuclein-induced toxicity, suggesting potential applications in neurodegenerative conditions (Simon C et al., 2022).
- Bone Density Preservation: By binding to Gpr54 in osteoclasts, it prevents bone loss through the activation of specific dephosphorylation pathways (Li Z et al., 2024).
- Cardiovascular Support: Studies show it increases myocardial collagen content and prevents cerebral aneurysm development by reducing Egr-1 expression (Radwańska P et al., 2023; Yu H et al., 2025).
- Joint & Cartilage Protection: The peptide protects against TNF-α-induced chondrocyte senescence via SIRT1/p53/p21 signaling, offering potential osteoarthritis relief (Qiu J et al., 2025).
- Anti-Tumor Properties: Evidence demonstrates that Kisspeptin-10 inhibits the proliferation and migration of certain cancer cells by regulating Wnt/β-catenin signaling (Guo C et al., 2025).
Where to Buy Kisspeptin-10
Research compound. Kisspeptin-10 is a research chemical, typically not FDA-approved for human consumption. Sale or use for human consumption may be illegal in your jurisdiction.
No compensation. PeptideStack does not endorse, verify, or receive compensation from any vendor. No affiliate or referral relationships.
Verify third-party COAs and consult a qualified healthcare provider before using any compound.
Side Effects
Common side effects:
- Injection site redness or swelling
- Mild flushing or temporary temperature fluctuations
- Headaches following administration
- Nausea or mild gastrointestinal discomfort
Rare or serious side effects:
- Hormonal imbalances with prolonged use
- Overstimulation of the hypothalamic-pituitary-gonadal axis
- Unintended alterations in insulin secretion and glucose metabolism
Kisspeptin-10 is not FDA-approved and is intended for research purposes only. Consult a qualified healthcare provider before use.
Mechanism of Action
Receptor activation is the primary mechanism by which the Kisspeptin-10 peptide exerts its biological effects. It acts as a high-affinity ligand for the G-protein coupled receptor 54 (GPR54), also known as the KISS1 receptor. Upon binding, it triggers a cascade of intracellular signaling pathways, most notably stimulating the secretion of gonadotropin-releasing hormone (GnRH) from the hypothalamus. This targeted activation is crucial for regulating the downstream release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Secondary signaling pathways mediate the diverse systemic Kisspeptin-10 benefits observed outside the reproductive system. In bone tissue, it activates Dusp18-mediated dephosphorylation of Src to inhibit osteoclast activity and prevent bone loss (Li Z et al., 2024). Furthermore, it modulates cellular senescence and apoptosis in various tissues by regulating SIRT1/p53/p21 and Wnt/β-catenin signaling networks (Qiu J et al., 2025; Guo C et al., 2025).
Origin & History
Discovery and isolation of kisspeptins originated in 1996 when researchers identified the KISS1 gene in Hershey, Pennsylvania—inspiring the name kisspeptin after the town's famous chocolate Kisses. Kisspeptin-10 is the shortest endogenous cleavage product of the primary 145-amino acid precursor protein that still retains full biological activity at the GPR54 receptor. Its identification revolutionized the understanding of reproductive endocrinology and pubertal onset. Clinical development has primarily focused on its role in reproductive health and metabolic function. Several Phase 3 clinical trials have investigated its effects on pubertal onset in boys and hypothalamic-pituitary-gonadal axis responsiveness in men (NCT03286517; NCT03315325). Currently, Kisspeptin-10 remains a research-only synthetic hormone and has not received FDA approval for medical use or human consumption.